Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 10 | 2022 | 215 | 3.980 |
Why?
|
| Mouth Neoplasms | 6 | 2020 | 206 | 2.220 |
Why?
|
| MicroRNAs | 5 | 2020 | 447 | 1.680 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2018 | 629 | 1.640 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2020 | 97 | 1.220 |
Why?
|
| RNA, Messenger | 11 | 2022 | 1664 | 1.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2018 | 756 | 1.040 |
Why?
|
| ELAV-Like Protein 1 | 2 | 2022 | 18 | 0.990 |
Why?
|
| Neoplasms | 3 | 2022 | 1667 | 0.990 |
Why?
|
| Exosomes | 4 | 2011 | 44 | 0.900 |
Why?
|
| Head and Neck Neoplasms | 3 | 2018 | 561 | 0.890 |
Why?
|
| RNA | 2 | 2016 | 171 | 0.880 |
Why?
|
| ELAV Proteins | 2 | 2013 | 17 | 0.850 |
Why?
|
| Saliva | 4 | 2011 | 142 | 0.820 |
Why?
|
| RNA Stability | 4 | 2020 | 55 | 0.780 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2020 | 20 | 0.730 |
Why?
|
| RNA, Long Noncoding | 2 | 2018 | 54 | 0.720 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 50 | 0.690 |
Why?
|
| CELF1 Protein | 2 | 2015 | 7 | 0.640 |
Why?
|
| Muscles | 1 | 2018 | 158 | 0.630 |
Why?
|
| Protein Isoforms | 1 | 2018 | 246 | 0.610 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2018 | 94 | 0.590 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 498 | 0.590 |
Why?
|
| Apoptosis | 3 | 2022 | 1641 | 0.580 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 1851 | 0.570 |
Why?
|
| Telomerase | 1 | 2016 | 85 | 0.530 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 194 | 0.530 |
Why?
|
| Cellular Senescence | 1 | 2016 | 112 | 0.520 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 384 | 0.510 |
Why?
|
| Stomatitis | 1 | 2013 | 8 | 0.460 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2013 | 22 | 0.460 |
Why?
|
| Gamma Rays | 1 | 2013 | 64 | 0.460 |
Why?
|
| Protease Inhibitors | 1 | 2013 | 76 | 0.450 |
Why?
|
| Caspase 3 | 1 | 2013 | 233 | 0.430 |
Why?
|
| Nanostructures | 2 | 2011 | 112 | 0.410 |
Why?
|
| Cell Communication | 1 | 2011 | 116 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2011 | 90 | 0.380 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 271 | 0.370 |
Why?
|
| Cytokines | 2 | 2012 | 866 | 0.370 |
Why?
|
| Smoking | 1 | 2018 | 1452 | 0.360 |
Why?
|
| Stress, Physiological | 1 | 2011 | 215 | 0.350 |
Why?
|
| Mice, Nude | 3 | 2021 | 294 | 0.340 |
Why?
|
| Humans | 22 | 2022 | 68618 | 0.330 |
Why?
|
| 3' Untranslated Regions | 3 | 2013 | 56 | 0.300 |
Why?
|
| Protein Binding | 6 | 2021 | 1027 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1293 | 0.270 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2018 | 43 | 0.250 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2016 | 231 | 0.240 |
Why?
|
| Mice | 7 | 2020 | 8474 | 0.240 |
Why?
|
| Ribonucleases | 2 | 2004 | 25 | 0.230 |
Why?
|
| Animals | 9 | 2021 | 20881 | 0.220 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2013 | 111 | 0.220 |
Why?
|
| Exoribonucleases | 2 | 2020 | 6 | 0.210 |
Why?
|
| Blotting, Western | 3 | 2015 | 954 | 0.210 |
Why?
|
| Cell Line | 3 | 2015 | 1752 | 0.200 |
Why?
|
| eIF-2 Kinase | 1 | 2022 | 49 | 0.200 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 58 | 0.200 |
Why?
|
| Transport Vesicles | 1 | 2021 | 5 | 0.190 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2021 | 10 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 1 | 2022 | 183 | 0.190 |
Why?
|
| Arginine | 1 | 2021 | 102 | 0.180 |
Why?
|
| ErbB Receptors | 2 | 2021 | 239 | 0.180 |
Why?
|
| Fragile X Syndrome | 1 | 2020 | 17 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 114 | 0.180 |
Why?
|
| Lysosomes | 1 | 2021 | 136 | 0.180 |
Why?
|
| Carcinogenesis | 1 | 2021 | 124 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2021 | 2689 | 0.170 |
Why?
|
| Base Sequence | 3 | 2012 | 1015 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 331 | 0.170 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 1447 | 0.160 |
Why?
|
| Heterografts | 2 | 2016 | 70 | 0.160 |
Why?
|
| Mutation | 2 | 2021 | 1213 | 0.160 |
Why?
|
| Papillomaviridae | 1 | 2018 | 104 | 0.150 |
Why?
|
| F-Box Proteins | 1 | 2017 | 14 | 0.150 |
Why?
|
| RNA Precursors | 1 | 2017 | 14 | 0.150 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2018 | 127 | 0.150 |
Why?
|
| Transfection | 2 | 2017 | 782 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2673 | 0.150 |
Why?
|
| Alternative Splicing | 1 | 2017 | 93 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 306 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 135 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 235 | 0.130 |
Why?
|
| Microscopy, Atomic Force | 3 | 2011 | 66 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 79 | 0.130 |
Why?
|
| Cell Membrane | 2 | 2021 | 525 | 0.130 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 132 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 68 | 0.130 |
Why?
|
| DNA Damage | 1 | 2016 | 190 | 0.130 |
Why?
|
| HEK293 Cells | 3 | 2021 | 326 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 492 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 1038 | 0.120 |
Why?
|
| Transcriptome | 1 | 2015 | 164 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1174 | 0.110 |
Why?
|
| Mouth Mucosa | 1 | 2013 | 51 | 0.110 |
Why?
|
| Keratinocytes | 1 | 2013 | 68 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2021 | 237 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 700 | 0.110 |
Why?
|
| bcl-Associated Death Protein | 1 | 2013 | 19 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 71 | 0.110 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 76 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 173 | 0.110 |
Why?
|
| Melanoma | 1 | 2016 | 335 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2018 | 2358 | 0.100 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2012 | 3 | 0.100 |
Why?
|
| Male | 3 | 2020 | 37321 | 0.100 |
Why?
|
| Interleukin-8 | 1 | 2012 | 71 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 1536 | 0.100 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2011 | 6 | 0.100 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2011 | 22 | 0.100 |
Why?
|
| Cobalt | 1 | 2011 | 37 | 0.100 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 92 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 1 | 2012 | 160 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 92 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2018 | 3705 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 196 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 219 | 0.090 |
Why?
|
| Substrate Specificity | 2 | 2006 | 234 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 1083 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 231 | 0.090 |
Why?
|
| Female | 4 | 2021 | 38074 | 0.090 |
Why?
|
| Proteins | 1 | 2004 | 474 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2012 | 330 | 0.090 |
Why?
|
| Ultracentrifugation | 1 | 2010 | 10 | 0.090 |
Why?
|
| Mechanical Phenomena | 1 | 2010 | 21 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 626 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 508 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1173 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 320 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 710 | 0.080 |
Why?
|
| Biomarkers | 2 | 2010 | 1593 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2010 | 254 | 0.070 |
Why?
|
| RNA Interference | 2 | 2017 | 266 | 0.070 |
Why?
|
| Polyadenylation | 1 | 2006 | 2 | 0.070 |
Why?
|
| Protein Transport | 2 | 2021 | 280 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2006 | 358 | 0.070 |
Why?
|
| Inflammation | 1 | 2012 | 1030 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 420 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 1033 | 0.060 |
Why?
|
| Poly A | 2 | 2004 | 14 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 209 | 0.060 |
Why?
|
| Aged | 1 | 2018 | 14862 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2004 | 123 | 0.050 |
Why?
|
| Adult | 2 | 2018 | 21403 | 0.050 |
Why?
|
| Kinetics | 2 | 2004 | 1047 | 0.050 |
Why?
|
| Multivesicular Bodies | 1 | 2021 | 3 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 99 | 0.050 |
Why?
|
| Methylation | 1 | 2021 | 56 | 0.050 |
Why?
|
| Biocatalysis | 1 | 2021 | 23 | 0.050 |
Why?
|
| Endosomes | 1 | 2021 | 45 | 0.050 |
Why?
|
| Endocytosis | 1 | 2021 | 113 | 0.050 |
Why?
|
| Middle Aged | 1 | 2018 | 21147 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 2791 | 0.050 |
Why?
|
| Ligands | 1 | 2021 | 317 | 0.040 |
Why?
|
| Autophagy | 1 | 2022 | 208 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2016 | 1692 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 791 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 434 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 331 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 597 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 65 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2017 | 22 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 13 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2017 | 37 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 50 | 0.040 |
Why?
|
| Protein Domains | 1 | 2017 | 74 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 32 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 231 | 0.040 |
Why?
|
| Exons | 1 | 2017 | 122 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 80 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 92 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 369 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 100 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 631 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2016 | 135 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 562 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 489 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 630 | 0.030 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2004 | 4 | 0.030 |
Why?
|
| RNA Caps | 1 | 2004 | 17 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 272 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2004 | 99 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1070 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2004 | 161 | 0.030 |
Why?
|
| Oligoribonucleotides | 1 | 2003 | 2 | 0.030 |
Why?
|
| Plasmids | 1 | 2004 | 258 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2004 | 235 | 0.030 |
Why?
|
| Cations | 1 | 2003 | 51 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 166 | 0.030 |
Why?
|
| Alleles | 1 | 2004 | 386 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2004 | 183 | 0.030 |
Why?
|
| Temperature | 1 | 2003 | 341 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 618 | 0.020 |
Why?
|
| Surface Properties | 1 | 2011 | 363 | 0.020 |
Why?
|
| Tetraspanin 30 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2010 | 19 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2010 | 81 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 507 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 236 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 167 | 0.020 |
Why?
|
| Gold | 1 | 2010 | 76 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 230 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 368 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2550 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 481 | 0.020 |
Why?
|
| Time Factors | 1 | 2004 | 4655 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 5300 | 0.010 |
Why?
|